Search Results 621-630 of 15871 for syphilis

  1. News - Vlad C. Vasile, M.D., Ph.D. - Mayo Clinic

    Make your tax-deductible gift and be part of the cutting-edge research and care that's changing medicine. Donate.

  2. Doxycycline (Oral Route) Precautions - Mayo Clinic

    Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant. If you think you ...

  3. Pegfilgrastim-Bmez (Subcutaneous Route) Side Effects - Mayo Clinic

    Check with your doctor immediately if any of the following side effects occur: Incidence not known. Black, tarry stools; bleeding gums; bleeding, ...

  4. Plague - Diagnosis and treatment - Mayo Clinic

    Treatment will likely start while your provider waits for the results of one or more laboratory tests to identify the Yersinia pestis bacteria. Samples for ...

  5. In Vitro Studies in Cold Agglutinin Disease - Mayo Clinic

    The purpose of this study is to assess antibody activity IN vitro in cold agglutinin disease (CAD) patients. Participation eligibility. Participant eligibility ...

  6. Publications - Lance A. Williams, III, M.D. - Mayo Clinic

    Cleeland CS, Keating KN, Cuffel B, Elbi C, Siegel JM, Gerlinger C, Symonds T, Sloan JA, Dueck AC, Bottomley A, Wang XS, Williams LA, Mendoza TR.

  7. John W. Sperling, M.D. - Doctors and Medical Staff - Mayo Clinic

    Rotator cuff surgery; Shoulder arthroscopy; Shoulder replacement revision; Shoulder replacement surgery · Interests. Primary and revision shoulder ...

  8. Rifampin (Oral Route) Proper Use - Mayo Clinic

    If you are taking itraconazole, do not use rifampin 2 weeks before and during itraconazole treatment. Dosing. The dose of this medicine will be different for ...

  9. Colectomy - Doctors & Departments - Mayo Clinic

    If you're having colon surgery, learn what to expect, the risks and how to prepare.

  10. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

    The purpose of this study is to determine if the invasive disease-free survival (iDFS) with T-DM1 and tucatinib is superior to the iDFS in the control arm (T- ...